The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis

Dermatol Surg. 2020 Aug;46(8):1054-1059. doi: 10.1097/DSS.0000000000002362.

Abstract

Background: Research evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective.

Objective: To compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuvant interventions (triple therapy).

Materials and methods: Systematic literature review and meta-analysis of combination treatment for keloids.

Results: After full-text review, we included 60 articles representing 5,547 keloids: 5,243 received dual therapy, 259 received triple therapy, and 45 received quadruple therapy (the latter 2 groups were combined for analysis). The difference in recurrence rates between dual (19%) and triple therapy (11.2%) was not significant (p = .343). However, the difference in recurrence rates between dual therapy using surgery and radiation (18.7%) and triple therapy using surgery, radiation, and a third intervention (7.7%) was significant (p = .002). The differences for surgery and intralesional triamcinolone (TAC) showed trends toward significance, because keloids treated with dual therapy (21.7%) had a higher recurrence rate than those treated with triple therapy comprised of surgery, TAC, and another intervention (13.7%; p = .099).

Conclusion: Triple therapy using surgery plus radiation and/or TAC as one of the adjuvant treatment modalities may achieve the lowest recurrence rates for keloids.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy / methods*
  • Dermatologic Surgical Procedures
  • Humans
  • Injections, Intralesional
  • Keloid / therapy*
  • Radiotherapy, Adjuvant
  • Recurrence
  • Triamcinolone / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Triamcinolone